Our aim is to make your business succeed. ProPharma Group’s experienced team commands a breadth and depth of knowledge pertaining to the FDA and EMA regulatory frameworks and can work with you to accomplish your regulatory and business objectives. We develop regulatory strategies for your product, providing a clear path forward through all the critical milestones to achieve a successful outcome. We can also help with your post-authorization regulatory needs, including the launch of your product, line extensions (LE) and variations, and maintaining your products’ optimal regulatory status throughout its lifecycle.
ProPharma Group continues to build upon our strong foundation of regulatory science with acquisitions that further globalize and deepen our service capabilities. Our integrated team of specialists has grown through uniting leading regulatory affairs companies such as the former Xendo Life Sciences and Sofus Regulatory Affairs, as well as The Weinberg Group and Southwood Research.
Our veteran team has over 30 years of experience using scientific knowledge to strategize viable and efficient drug and device development pathways to achieve successful outcomes with regulatory agencies. Explore all the ways that ProPharma Group can support your product pipeline throughout the entire product lifecycle:
